Viewing Study NCT01975012


Ignite Creation Date: 2025-12-26 @ 10:43 PM
Ignite Modification Date: 2026-01-11 @ 3:17 PM
Study NCT ID: NCT01975012
Status: WITHDRAWN
Last Update Posted: 2021-11-01
First Post: 2013-10-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, Drug Interactions, and Antiviral Activity of Rilpivirine in Antiretroviral-Naive HIV-Infected Children Less Than 12 Years of Age
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-09
Start Date Type: None
Primary Completion Date: 2018-05
Primary Completion Date Type: ESTIMATED
Completion Date: None
Completion Date Type: None
First Submit Date: 2013-10-28
First Submit QC Date: None
Study First Post Date: 2013-11-04
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-10-28
Last Update Post Date: 2021-11-01
Last Update Post Date Type: ACTUAL